Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122703234 | 12270323 | 4 | F | 20150605 | 20160803 | 20160415 | 20160808 | EXP | PHHY2015CA070031 | NOVARTIS | 74.64 | YR | M | Y | 0.00000 | 20160808 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122703234 | 12270323 | 1 | PS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | UNK UG, ONCE/SINGLE | 19667 | 1X | |||||||||
| 122703234 | 12270323 | 2 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Intramuscular | 5 MG, UNK | 19667 | 5 | MG | ||||||||
| 122703234 | 12270323 | 3 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | 450 UG, ONCE/SINGLE (TEST DOSE) | 19667 | 450 | UG | 1X | |||||||
| 122703234 | 12270323 | 4 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO, ONCE A MONTH | U | 0 | 30 | MG | /month | ||||||
| 122703234 | 12270323 | 5 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122703234 | 12270323 | 1 | Carcinoid tumour pulmonary |
| 122703234 | 12270323 | 4 | Carcinoid tumour pulmonary |
| 122703234 | 12270323 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122703234 | 12270323 | HO |
| 122703234 | 12270323 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122703234 | 12270323 | Blood pressure systolic increased | |
| 122703234 | 12270323 | Bone cancer | |
| 122703234 | 12270323 | Bradycardia | |
| 122703234 | 12270323 | Dizziness | |
| 122703234 | 12270323 | Erythema | |
| 122703234 | 12270323 | Fatigue | |
| 122703234 | 12270323 | Headache | |
| 122703234 | 12270323 | Hypokinesia | |
| 122703234 | 12270323 | Incorrect dose administered | |
| 122703234 | 12270323 | Incorrect route of drug administration | |
| 122703234 | 12270323 | Injection site erythema | |
| 122703234 | 12270323 | Injection site inflammation | |
| 122703234 | 12270323 | Injection site mass | |
| 122703234 | 12270323 | Injection site nerve damage | |
| 122703234 | 12270323 | Injection site pain | |
| 122703234 | 12270323 | Injection site reaction | |
| 122703234 | 12270323 | Needle issue | |
| 122703234 | 12270323 | Peripheral swelling | |
| 122703234 | 12270323 | Product use issue | |
| 122703234 | 12270323 | Rash | |
| 122703234 | 12270323 | Sinus disorder | |
| 122703234 | 12270323 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122703234 | 12270323 | 1 | 20150605 | 20150605 | 0 | |
| 122703234 | 12270323 | 2 | 20150902 | 0 | ||
| 122703234 | 12270323 | 3 | 20150902 | 20150902 | 0 | |
| 122703234 | 12270323 | 4 | 20150902 | 0 |